Dr Sam Higgins BSc MSc PhD
Dr Sam Higgins obtained a BSc in Pharmacology from the University of Hertfordshire and an MSc in Biomedical Sciences from the University of Portsmouth, during which time she first started working in the brain tumour research field. She progressed further to do a PhD funded by Ali’s Dream, Brainstrust and the Isle of Man Anticancer Association. The main focus of her research was the potential of therapeutic targeting the NG2 protein on paediatric and adult brain tumour cells using a novel immunotoxin approach. Since completion of her PhD, she has been undertaking postdoctoral research, funded by Brain Tumour Research, where her ongoing interests involve the manipulation of the tumour micro-environment to influence the way in which cells make energy to survive, and use this knowledge to improve tumour cell sensitivity to mitochondrially-acting pro-apoptotic agents such as tricyclic drugs.